SlideShare a Scribd company logo
1 of 19
Aminoglycoside
& Vancomycin
Dosing
..a conversation..
………
Part 1
- dosing considerations -
“All drugs are controlled poisons”.
“Drugs don’t have dosages…
……patients have dosages….”.
Goldilocks Principle
Goldilocks principle states that
something must fall within certain
margins, as opposed to reaching
extremes. When the effects of the
principle are observed, it is known
as the Goldilocks effect.
Dosing objective:
Hit the therapeutic window
> Too much = toxicity.
> Right dose: eradicate the
bacteria without injuring the
patient.
> Too little = ineffective.
“Pharmacy to dose”
Essentially 3 things:
- a dose
- a frequency (interval)
- monitoring labs
Dosing our pts is problematic
 Lack of experience/practice on part of
prescribers, nursing staff and pharmacists
in dosing aminoglycosides & vancomycin.
 Patients difficult to assess, remote to both
prescriber & pharmacy staff.
 Delay in lab results. We’re not 24/7.
 Inherently difficult population to dose
(elderly, bedridden, other potentially
nephrotoxic medications).
The dose?
Dosage based predominantly on:
Size of patient
Site of infection
Severity of infection
Resistance of organism
Hydration status of patient
…and 163 other variables…
The dose?
How much?
Think
conceptually
Big people get big
doses….
Little people get little doses….
Big dogs get
big doses…
Little dogs get little
doses…
The interval?
Dosing interval based on:
Clearance – the speed at which
the body eliminates the drug
(predominantly renal, with a
small amount of clearance from
the liver)
Younger patients who
are otherwise
healthy?
Think shorter dosing
intervals (more
frequent dosing,
i.e., Q4H,Q6H, Q8H).
Elderly patients and
patients with renal
insufficiency?
Think longer dosing
intervals (less frequent
dosing, i.e., q12h,
q24h, q48h, q72h)…
Quick review of dosing
concepts…..
Dose?
Big patients =
big doses
Little patients =
little doses
Interval?
Younger and
otherwise healthy
patients = more
frequent dosing.
Older, elderly patients
and patients with
renal insufficiency =
less frequent dosing.
Serum Creatinine – it’s just a number.
Before you put the numbers in the calculator
think about the pt.
If your patient:
- has a stable renal function SCr/UOP AND
- is within the age range (18-65 years) AND
- is reasonably well nourished/hydrated AND
- doesn’t have renal disease (i.e., not
diabetic, no diuretics, good urine output, etc.)
The calculated answer may be reasonably
close to actual clearance.
CrCl: which equation??
Simplified 4-variable MDRD study formula?
CKD-EPI equation?
Cockcroft-Gault based on:
CG - Total Body Weight?
CG - Ideal Body Weight?
CG - Adjusted Body Weight? – use this one….
Fudge factor(s)?
→ If the reported SCr is < 1 mg/dL and
the patient is:
Is older than 65 years of age and/or
Is sedentary/bedridden, paralysis
and/or
Has poor nutritional status and/or
Has poor urine output
Fudge factor(s)
→ Consider using “1 mg/dL” in your
calculations and/or
→“Lowballing” the dose, i.e.,
- if the recommended peak level for the
condition is 8-10 mcg/ml, consider using 6-8
mcg/ml in your calculations.
- if the recommended trough level for the
condition is <1 mcg/ml, consider using 0.3-
0.5 mcg/ml in your calculations.
Why fudge the numbers?
For patients:
- who are elderly (>65 years).
- who have diminished muscle mass
(bedridden, paralysis, malnourished,
who are on diuretics, who are volume
overloaded, etc.), the calculated CrCl
tend to overestimate the actual
clearance.
Fudging will give a more
conservative dose
Using a larger than true SCr number will
result in a lower calculated CrCl
(slower clearance).
Fudging will give you a lower dose
and/or a longer dosing interval.

More Related Content

What's hot

Protocol of ns 2014 copy
Protocol of ns 2014   copyProtocol of ns 2014   copy
Protocol of ns 2014 copyFarragBahbah
 
Paclitaxel 6 mgml concentrate for solution for infusion smpc taj pharmaceuti...
Paclitaxel 6 mgml concentrate for solution for infusion smpc  taj pharmaceuti...Paclitaxel 6 mgml concentrate for solution for infusion smpc  taj pharmaceuti...
Paclitaxel 6 mgml concentrate for solution for infusion smpc taj pharmaceuti...Taj Pharma
 
L. berarducci new cholesterol management guidelines
L. berarducci new cholesterol management guidelinesL. berarducci new cholesterol management guidelines
L. berarducci new cholesterol management guidelinesAlysia Smith
 
Ovarian cancer regimens
Ovarian cancer regimensOvarian cancer regimens
Ovarian cancer regimensArishajunaid
 
Cabazitaxel 60 mg concentrate and solvent for solution for infusion smpc taj...
Cabazitaxel 60 mg concentrate and solvent for solution for infusion smpc  taj...Cabazitaxel 60 mg concentrate and solvent for solution for infusion smpc  taj...
Cabazitaxel 60 mg concentrate and solvent for solution for infusion smpc taj...Taj Pharma
 
Albendazole 400 mg tablets smpc taj pharmaceuticals
Albendazole 400 mg tablets smpc  taj pharmaceuticalsAlbendazole 400 mg tablets smpc  taj pharmaceuticals
Albendazole 400 mg tablets smpc taj pharmaceuticalsTaj Pharma
 
Infusion de 4 horas de tazocin
Infusion de 4 horas de tazocinInfusion de 4 horas de tazocin
Infusion de 4 horas de tazocineduardo de avila
 
Aminoglycosides dosing and duration of therapy
Aminoglycosides dosing and duration of therapyAminoglycosides dosing and duration of therapy
Aminoglycosides dosing and duration of therapyJuan Celis Salinas
 
Kanamycin Injection Taj Pharma SmPC
Kanamycin Injection Taj Pharma SmPCKanamycin Injection Taj Pharma SmPC
Kanamycin Injection Taj Pharma SmPCTajPharmaQC
 
Treatment of Malaria
Treatment of MalariaTreatment of Malaria
Treatment of MalariaVishnu Pudi
 
Colchicine for management of acute gout; an evidence based approach
Colchicine for management of acute gout; an evidence based approachColchicine for management of acute gout; an evidence based approach
Colchicine for management of acute gout; an evidence based approachreyrey4thewin
 
Trasturel 150mg injection
Trasturel 150mg injectionTrasturel 150mg injection
Trasturel 150mg injectionsharonpaula
 
Protocol of use for vancomycin
Protocol of use for vancomycinProtocol of use for vancomycin
Protocol of use for vancomycinAhlam Sundus
 
Betamethasone 0.5 mg soluble tablets smpc taj pharmaceuticals
Betamethasone 0.5 mg soluble tablets smpc  taj pharmaceuticalsBetamethasone 0.5 mg soluble tablets smpc  taj pharmaceuticals
Betamethasone 0.5 mg soluble tablets smpc taj pharmaceuticalsTaj Pharma
 
Gentamicin 40 mg per ml injection smpc taj pharmaceuticals
Gentamicin 40 mg per ml injection smpc  taj pharmaceuticalsGentamicin 40 mg per ml injection smpc  taj pharmaceuticals
Gentamicin 40 mg per ml injection smpc taj pharmaceuticalsTaj Pharma
 
Acetylcysteine Injection USP Taj Pharma SmPC
Acetylcysteine Injection USP Taj Pharma SmPCAcetylcysteine Injection USP Taj Pharma SmPC
Acetylcysteine Injection USP Taj Pharma SmPCTajPharmaQC
 
Pemetrexed dr. varun
Pemetrexed dr. varunPemetrexed dr. varun
Pemetrexed dr. varunVarun Goel
 

What's hot (20)

Protocol of ns 2014 copy
Protocol of ns 2014   copyProtocol of ns 2014   copy
Protocol of ns 2014 copy
 
Paclitaxel 6 mgml concentrate for solution for infusion smpc taj pharmaceuti...
Paclitaxel 6 mgml concentrate for solution for infusion smpc  taj pharmaceuti...Paclitaxel 6 mgml concentrate for solution for infusion smpc  taj pharmaceuti...
Paclitaxel 6 mgml concentrate for solution for infusion smpc taj pharmaceuti...
 
L. berarducci new cholesterol management guidelines
L. berarducci new cholesterol management guidelinesL. berarducci new cholesterol management guidelines
L. berarducci new cholesterol management guidelines
 
Ovarian cancer regimens
Ovarian cancer regimensOvarian cancer regimens
Ovarian cancer regimens
 
Cabazitaxel 60 mg concentrate and solvent for solution for infusion smpc taj...
Cabazitaxel 60 mg concentrate and solvent for solution for infusion smpc  taj...Cabazitaxel 60 mg concentrate and solvent for solution for infusion smpc  taj...
Cabazitaxel 60 mg concentrate and solvent for solution for infusion smpc taj...
 
Albendazole 400 mg tablets smpc taj pharmaceuticals
Albendazole 400 mg tablets smpc  taj pharmaceuticalsAlbendazole 400 mg tablets smpc  taj pharmaceuticals
Albendazole 400 mg tablets smpc taj pharmaceuticals
 
GCA treatment
GCA treatmentGCA treatment
GCA treatment
 
Infusion de 4 horas de tazocin
Infusion de 4 horas de tazocinInfusion de 4 horas de tazocin
Infusion de 4 horas de tazocin
 
Aminoglycosides dosing and duration of therapy
Aminoglycosides dosing and duration of therapyAminoglycosides dosing and duration of therapy
Aminoglycosides dosing and duration of therapy
 
Calculation of Doses
Calculation of DosesCalculation of Doses
Calculation of Doses
 
Kanamycin Injection Taj Pharma SmPC
Kanamycin Injection Taj Pharma SmPCKanamycin Injection Taj Pharma SmPC
Kanamycin Injection Taj Pharma SmPC
 
Treatment of Malaria
Treatment of MalariaTreatment of Malaria
Treatment of Malaria
 
PCSK9 Inhibitors
PCSK9 InhibitorsPCSK9 Inhibitors
PCSK9 Inhibitors
 
Colchicine for management of acute gout; an evidence based approach
Colchicine for management of acute gout; an evidence based approachColchicine for management of acute gout; an evidence based approach
Colchicine for management of acute gout; an evidence based approach
 
Trasturel 150mg injection
Trasturel 150mg injectionTrasturel 150mg injection
Trasturel 150mg injection
 
Protocol of use for vancomycin
Protocol of use for vancomycinProtocol of use for vancomycin
Protocol of use for vancomycin
 
Betamethasone 0.5 mg soluble tablets smpc taj pharmaceuticals
Betamethasone 0.5 mg soluble tablets smpc  taj pharmaceuticalsBetamethasone 0.5 mg soluble tablets smpc  taj pharmaceuticals
Betamethasone 0.5 mg soluble tablets smpc taj pharmaceuticals
 
Gentamicin 40 mg per ml injection smpc taj pharmaceuticals
Gentamicin 40 mg per ml injection smpc  taj pharmaceuticalsGentamicin 40 mg per ml injection smpc  taj pharmaceuticals
Gentamicin 40 mg per ml injection smpc taj pharmaceuticals
 
Acetylcysteine Injection USP Taj Pharma SmPC
Acetylcysteine Injection USP Taj Pharma SmPCAcetylcysteine Injection USP Taj Pharma SmPC
Acetylcysteine Injection USP Taj Pharma SmPC
 
Pemetrexed dr. varun
Pemetrexed dr. varunPemetrexed dr. varun
Pemetrexed dr. varun
 

Viewers also liked

Drug dosage adjustment using renal estimation equations. A review of the lite...
Drug dosage adjustment using renal estimation equations. A review of the lite...Drug dosage adjustment using renal estimation equations. A review of the lite...
Drug dosage adjustment using renal estimation equations. A review of the lite...Greenberg, Eric
 
Infective Complications In Pd
Infective Complications In PdInfective Complications In Pd
Infective Complications In Pdedwinchowyw
 
Peak & trough
Peak & trough   Peak & trough
Peak & trough wcmc
 
Vancomycin hydrochloride
Vancomycin hydrochlorideVancomycin hydrochloride
Vancomycin hydrochlorideChris W
 
Toxicity of aminoglycoside antibiotics
Toxicity of aminoglycoside antibioticsToxicity of aminoglycoside antibiotics
Toxicity of aminoglycoside antibioticsAjith Y
 
Antibiotics That Require Frequent Monitoring
Antibiotics That Require Frequent MonitoringAntibiotics That Require Frequent Monitoring
Antibiotics That Require Frequent MonitoringLouie Ray
 
Vancomycin血中濃度監測(TDM)
Vancomycin血中濃度監測(TDM)Vancomycin血中濃度監測(TDM)
Vancomycin血中濃度監測(TDM)Ming Chia Lee
 
Part 2 - Aminoglycoside Vancomycin dosing
Part 2 - Aminoglycoside  Vancomycin dosingPart 2 - Aminoglycoside  Vancomycin dosing
Part 2 - Aminoglycoside Vancomycin dosingJeff Tollison
 
Drug profiles of Vancomycin, Prednisone and Salbutamol
Drug profiles of Vancomycin, Prednisone and SalbutamolDrug profiles of Vancomycin, Prednisone and Salbutamol
Drug profiles of Vancomycin, Prednisone and SalbutamolKomal Haleem
 
Aminoglycoside ppt
Aminoglycoside pptAminoglycoside ppt
Aminoglycoside pptneetu ojha
 
Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)Dr. Ravi Sankar
 
Aminoglycoside and spectinomycin
Aminoglycoside and spectinomycinAminoglycoside and spectinomycin
Aminoglycoside and spectinomycinYjnuuuhhh
 
Linea de tiempo teorias de la personalidad
Linea de tiempo teorias de la personalidadLinea de tiempo teorias de la personalidad
Linea de tiempo teorias de la personalidadCarolina
 

Viewers also liked (16)

Drug dosage adjustment using renal estimation equations. A review of the lite...
Drug dosage adjustment using renal estimation equations. A review of the lite...Drug dosage adjustment using renal estimation equations. A review of the lite...
Drug dosage adjustment using renal estimation equations. A review of the lite...
 
Muztaba
MuztabaMuztaba
Muztaba
 
Infective Complications In Pd
Infective Complications In PdInfective Complications In Pd
Infective Complications In Pd
 
Peak & trough
Peak & trough   Peak & trough
Peak & trough
 
Vancomycin hydrochloride
Vancomycin hydrochlorideVancomycin hydrochloride
Vancomycin hydrochloride
 
Toxicity of aminoglycoside antibiotics
Toxicity of aminoglycoside antibioticsToxicity of aminoglycoside antibiotics
Toxicity of aminoglycoside antibiotics
 
Antibiotics That Require Frequent Monitoring
Antibiotics That Require Frequent MonitoringAntibiotics That Require Frequent Monitoring
Antibiotics That Require Frequent Monitoring
 
Vancomycin血中濃度監測(TDM)
Vancomycin血中濃度監測(TDM)Vancomycin血中濃度監測(TDM)
Vancomycin血中濃度監測(TDM)
 
Part 2 - Aminoglycoside Vancomycin dosing
Part 2 - Aminoglycoside  Vancomycin dosingPart 2 - Aminoglycoside  Vancomycin dosing
Part 2 - Aminoglycoside Vancomycin dosing
 
Drug profiles of Vancomycin, Prednisone and Salbutamol
Drug profiles of Vancomycin, Prednisone and SalbutamolDrug profiles of Vancomycin, Prednisone and Salbutamol
Drug profiles of Vancomycin, Prednisone and Salbutamol
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
 
Aminoglycoside ppt
Aminoglycoside pptAminoglycoside ppt
Aminoglycoside ppt
 
Vancomycin
VancomycinVancomycin
Vancomycin
 
Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)
 
Aminoglycoside and spectinomycin
Aminoglycoside and spectinomycinAminoglycoside and spectinomycin
Aminoglycoside and spectinomycin
 
Linea de tiempo teorias de la personalidad
Linea de tiempo teorias de la personalidadLinea de tiempo teorias de la personalidad
Linea de tiempo teorias de la personalidad
 

Similar to Part 1 - Aminoglycoside Vancomycin dosing

Pediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulasPediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulasNEHA MALIK
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UGamitakashyap1
 
August prescribing update
August prescribing updateAugust prescribing update
August prescribing updateJoleHannan
 
10 practical tips to make type 1 diabetes work for you tlc retreat 2013 ponder
10 practical tips to make type 1 diabetes work for you tlc retreat 2013 ponder10 practical tips to make type 1 diabetes work for you tlc retreat 2013 ponder
10 practical tips to make type 1 diabetes work for you tlc retreat 2013 ponderKevin McMahon
 
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...PASaskatchewan
 
C1 cda cpg quick reference guide update 2015
C1 cda cpg quick reference guide update 2015C1 cda cpg quick reference guide update 2015
C1 cda cpg quick reference guide update 2015Diabetes for all
 
Door county memorial blood glucose - ppt-2012
Door county memorial   blood glucose - ppt-2012Door county memorial   blood glucose - ppt-2012
Door county memorial blood glucose - ppt-201214021888
 
Type 2 diabetes.pptx
Type 2 diabetes.pptxType 2 diabetes.pptx
Type 2 diabetes.pptxRimChamsine1
 
F inal presentation vernon ems glucometer smr 2015
F inal presentation vernon ems glucometer smr 2015F inal presentation vernon ems glucometer smr 2015
F inal presentation vernon ems glucometer smr 2015cmarth
 
3. Clinical Phk-Dosing in special Population & TDM.pptx
3. Clinical Phk-Dosing in special Population & TDM.pptx3. Clinical Phk-Dosing in special Population & TDM.pptx
3. Clinical Phk-Dosing in special Population & TDM.pptxjiregna5
 
Personalized Diabetes Management
Personalized Diabetes ManagementPersonalized Diabetes Management
Personalized Diabetes ManagementAshley Odom
 
C1 cda in hospital management of diabetes 2015
C1 cda in hospital management of diabetes 2015C1 cda in hospital management of diabetes 2015
C1 cda in hospital management of diabetes 2015Diabetes for all
 
Research inclusion and exclusion criteria DrMajdi
Research inclusion and exclusion criteria DrMajdiResearch inclusion and exclusion criteria DrMajdi
Research inclusion and exclusion criteria DrMajdiDr. Majdi Al Jasim
 
Diabetes Medications
Diabetes MedicationsDiabetes Medications
Diabetes Medicationskwelter
 
Dia care herbal powder
Dia care herbal powderDia care herbal powder
Dia care herbal powderSanjay Antala
 
Beyond metformin dr clayton feb 22
Beyond metformin dr clayton feb 22Beyond metformin dr clayton feb 22
Beyond metformin dr clayton feb 22Ihsaan Peer
 

Similar to Part 1 - Aminoglycoside Vancomycin dosing (20)

Roller Coaster of Insulin Therapy Rationale for insulin therapy in type 2 di...
Roller Coaster of Insulin Therapy Rationale for insulin therapy  in type 2 di...Roller Coaster of Insulin Therapy Rationale for insulin therapy  in type 2 di...
Roller Coaster of Insulin Therapy Rationale for insulin therapy in type 2 di...
 
Pediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulasPediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulas
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
 
August prescribing update
August prescribing updateAugust prescribing update
August prescribing update
 
10 practical tips to make type 1 diabetes work for you tlc retreat 2013 ponder
10 practical tips to make type 1 diabetes work for you tlc retreat 2013 ponder10 practical tips to make type 1 diabetes work for you tlc retreat 2013 ponder
10 practical tips to make type 1 diabetes work for you tlc retreat 2013 ponder
 
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
 
C1 cda cpg quick reference guide update 2015
C1 cda cpg quick reference guide update 2015C1 cda cpg quick reference guide update 2015
C1 cda cpg quick reference guide update 2015
 
Door county memorial blood glucose - ppt-2012
Door county memorial   blood glucose - ppt-2012Door county memorial   blood glucose - ppt-2012
Door county memorial blood glucose - ppt-2012
 
Investigations of d m
Investigations of d mInvestigations of d m
Investigations of d m
 
Type 2 diabetes.pptx
Type 2 diabetes.pptxType 2 diabetes.pptx
Type 2 diabetes.pptx
 
F inal presentation vernon ems glucometer smr 2015
F inal presentation vernon ems glucometer smr 2015F inal presentation vernon ems glucometer smr 2015
F inal presentation vernon ems glucometer smr 2015
 
3. Clinical Phk-Dosing in special Population & TDM.pptx
3. Clinical Phk-Dosing in special Population & TDM.pptx3. Clinical Phk-Dosing in special Population & TDM.pptx
3. Clinical Phk-Dosing in special Population & TDM.pptx
 
Personalized Diabetes Management
Personalized Diabetes ManagementPersonalized Diabetes Management
Personalized Diabetes Management
 
C1 cda in hospital management of diabetes 2015
C1 cda in hospital management of diabetes 2015C1 cda in hospital management of diabetes 2015
C1 cda in hospital management of diabetes 2015
 
Research inclusion and exclusion criteria DrMajdi
Research inclusion and exclusion criteria DrMajdiResearch inclusion and exclusion criteria DrMajdi
Research inclusion and exclusion criteria DrMajdi
 
Diabetes Medications
Diabetes MedicationsDiabetes Medications
Diabetes Medications
 
Dia care herbal powder
Dia care herbal powderDia care herbal powder
Dia care herbal powder
 
Admit orders
Admit ordersAdmit orders
Admit orders
 
Beyond metformin dr clayton feb 22
Beyond metformin dr clayton feb 22Beyond metformin dr clayton feb 22
Beyond metformin dr clayton feb 22
 
DIABETES.pptx
DIABETES.pptxDIABETES.pptx
DIABETES.pptx
 

Part 1 - Aminoglycoside Vancomycin dosing

  • 2. Part 1 - dosing considerations - “All drugs are controlled poisons”. “Drugs don’t have dosages… ……patients have dosages….”.
  • 3. Goldilocks Principle Goldilocks principle states that something must fall within certain margins, as opposed to reaching extremes. When the effects of the principle are observed, it is known as the Goldilocks effect.
  • 4. Dosing objective: Hit the therapeutic window > Too much = toxicity. > Right dose: eradicate the bacteria without injuring the patient. > Too little = ineffective.
  • 5. “Pharmacy to dose” Essentially 3 things: - a dose - a frequency (interval) - monitoring labs
  • 6. Dosing our pts is problematic  Lack of experience/practice on part of prescribers, nursing staff and pharmacists in dosing aminoglycosides & vancomycin.  Patients difficult to assess, remote to both prescriber & pharmacy staff.  Delay in lab results. We’re not 24/7.  Inherently difficult population to dose (elderly, bedridden, other potentially nephrotoxic medications).
  • 7. The dose? Dosage based predominantly on: Size of patient Site of infection Severity of infection Resistance of organism Hydration status of patient …and 163 other variables…
  • 8. The dose? How much? Think conceptually Big people get big doses…. Little people get little doses….
  • 9. Big dogs get big doses… Little dogs get little doses…
  • 10. The interval? Dosing interval based on: Clearance – the speed at which the body eliminates the drug (predominantly renal, with a small amount of clearance from the liver)
  • 11. Younger patients who are otherwise healthy? Think shorter dosing intervals (more frequent dosing, i.e., Q4H,Q6H, Q8H).
  • 12. Elderly patients and patients with renal insufficiency? Think longer dosing intervals (less frequent dosing, i.e., q12h, q24h, q48h, q72h)…
  • 13. Quick review of dosing concepts….. Dose? Big patients = big doses Little patients = little doses Interval? Younger and otherwise healthy patients = more frequent dosing. Older, elderly patients and patients with renal insufficiency = less frequent dosing.
  • 14. Serum Creatinine – it’s just a number. Before you put the numbers in the calculator think about the pt. If your patient: - has a stable renal function SCr/UOP AND - is within the age range (18-65 years) AND - is reasonably well nourished/hydrated AND - doesn’t have renal disease (i.e., not diabetic, no diuretics, good urine output, etc.) The calculated answer may be reasonably close to actual clearance.
  • 15. CrCl: which equation?? Simplified 4-variable MDRD study formula? CKD-EPI equation? Cockcroft-Gault based on: CG - Total Body Weight? CG - Ideal Body Weight? CG - Adjusted Body Weight? – use this one….
  • 16. Fudge factor(s)? → If the reported SCr is < 1 mg/dL and the patient is: Is older than 65 years of age and/or Is sedentary/bedridden, paralysis and/or Has poor nutritional status and/or Has poor urine output
  • 17. Fudge factor(s) → Consider using “1 mg/dL” in your calculations and/or →“Lowballing” the dose, i.e., - if the recommended peak level for the condition is 8-10 mcg/ml, consider using 6-8 mcg/ml in your calculations. - if the recommended trough level for the condition is <1 mcg/ml, consider using 0.3- 0.5 mcg/ml in your calculations.
  • 18. Why fudge the numbers? For patients: - who are elderly (>65 years). - who have diminished muscle mass (bedridden, paralysis, malnourished, who are on diuretics, who are volume overloaded, etc.), the calculated CrCl tend to overestimate the actual clearance.
  • 19. Fudging will give a more conservative dose Using a larger than true SCr number will result in a lower calculated CrCl (slower clearance). Fudging will give you a lower dose and/or a longer dosing interval.